MwanzoDMN • FRA
add
Diamyd Medical AB
Bei iliyotangulia
€ 0.85
Bei za siku
€ 0.86 - € 0.94
Bei za mwaka
€ 0.65 - € 1.62
Thamani ya kampuni katika soko
1.32B SEK
Wastani wa hisa zilizouzwa
15.00
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
STO
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (SEK) | Ago 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | elfu 19.00 | 5.56% |
Matumizi ya uendeshaji wa biashara | 45.81M | 0.17% |
Mapato halisi | -44.86M | 9.80% |
Kiwango cha faida halisi | elfu -236.13 | 14.55% |
Mapato kwa kila hisa | — | — |
EBITDA | -44.87M | 0.46% |
Asilimia ya kodi ya mapato | — | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (SEK) | Ago 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 277.18M | 109.41% |
Jumla ya mali | 352.64M | 62.48% |
Jumla ya dhima | 72.64M | 2.14% |
Jumla ya hisa | 280.00M | — |
hisa zilizosalia | 137.50M | — |
Uwiano wa bei na thamani | 0.42 | — |
Faida inayotokana na mali | -30.90% | — |
Faida inayotokana mtaji | -38.46% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (SEK) | Ago 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -44.86M | 9.80% |
Pesa kutokana na shughuli | -35.94M | -23.25% |
Pesa kutokana na uwekezaji | -2.37M | -112.60% |
Pesa kutokana na ufadhili | -1.07M | -28.16% |
Mabadiliko halisi ya pesa taslimu | -42.08M | -309.55% |
Mtiririko huru wa pesa | -29.96M | -101.06% |
Kuhusu
Diamyd Medical AB is a small biotechnology company headquartered in Stockholm, Sweden that focuses on immune modifying therapies for diabetes. The company is developing two products.
The company is headquartered in Stockholm, and maintains a manufacturing facility in Umeå. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1984
Tovuti
Wafanyakazi
39
